vs
Side-by-side financial comparison of Scinai Immunotherapeutics Ltd. (SCNI) and TMC the metals Co Inc. (TMC). Click either name above to swap in a different company.
TMC the metals Co Inc. is the larger business by last-quarter revenue ($1.3M vs $773.0K, roughly 1.7× Scinai Immunotherapeutics Ltd.). On growth, TMC the metals Co Inc. posted the faster year-over-year revenue change (2425.5% vs 172.2%).
The Metals Company, formerly DeepGreen Metals, is a Canadian deep sea mining exploration company. The company focuses on the mining of polymetallic nodules in the Clarion Clipperton Zone of the Pacific.
SCNI vs TMC — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $773.0K | $1.3M |
| Net Profit | — | $-40.4M |
| Gross Margin | — | — |
| Operating Margin | — | -3470.9% |
| Net Margin | — | -3136.5% |
| Revenue YoY | 172.2% | 2425.5% |
| Net Profit YoY | — | -151.5% |
| EPS (diluted) | — | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.3M | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | $773.0K | — | ||
| Q2 24 | $284.0K | — | ||
| Q4 23 | — | $205.0K | ||
| Q3 23 | — | $319.0K | ||
| Q1 23 | — | $454.0K | ||
| Q4 22 | — | $567.0K |
| Q4 25 | — | $-40.4M | ||
| Q3 25 | — | $-184.5M | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $-33.5M | ||
| Q3 23 | — | $-12.5M | ||
| Q1 23 | — | $-13.7M | ||
| Q4 22 | — | $-109.6M |
| Q4 25 | — | -3470.9% | ||
| Q3 25 | — | -4134.4% | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | -16223.9% | ||
| Q3 23 | — | -3924.1% | ||
| Q1 23 | — | -2947.8% | ||
| Q4 22 | — | -19625.2% |
| Q4 25 | — | -3136.5% | ||
| Q3 25 | — | -13780.2% | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | -16321.5% | ||
| Q3 23 | — | -3908.2% | ||
| Q1 23 | — | -3028.2% | ||
| Q4 22 | — | -19324.3% |
| Q4 25 | — | $0.11 | ||
| Q3 25 | — | $0.46 | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $0.12 | ||
| Q3 23 | — | $0.04 | ||
| Q1 23 | — | $0.05 | ||
| Q4 22 | — | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $989.0K | $117.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.9M | $-33.4M |
| Total Assets | $11.8M | $181.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $117.6M | ||
| Q3 25 | — | $115.6M | ||
| Q2 25 | $989.0K | — | ||
| Q2 24 | $3.1M | — | ||
| Q4 23 | — | $6.8M | ||
| Q3 23 | — | $22.5M | ||
| Q1 23 | — | $28.4M | ||
| Q4 22 | — | $46.9M |
| Q4 25 | — | $-33.4M | ||
| Q3 25 | — | $-40.6M | ||
| Q2 25 | $7.9M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q4 23 | — | $10.9M | ||
| Q3 23 | — | $41.6M | ||
| Q1 23 | — | $41.8M | ||
| Q4 22 | — | $41.5M |
| Q4 25 | — | $181.6M | ||
| Q3 25 | — | $175.6M | ||
| Q2 25 | $11.8M | — | ||
| Q2 24 | $14.9M | — | ||
| Q4 23 | — | $68.9M | ||
| Q3 23 | — | $87.8M | ||
| Q1 23 | — | $85.5M | ||
| Q4 22 | — | $94.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-11.4M |
| Free Cash FlowOCF − Capex | — | $-11.5M |
| FCF MarginFCF / Revenue | — | -889.8% |
| Capex IntensityCapex / Revenue | — | 8.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-11.4M | ||
| Q3 25 | — | $-11.5M | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $-15.2M | ||
| Q3 23 | — | $-12.5M | ||
| Q1 23 | — | $-23.5M | ||
| Q4 22 | — | $-19.8M |
| Q4 25 | — | $-11.5M | ||
| Q3 25 | — | $-11.5M | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | $-12.6M | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
| Q4 25 | — | -889.8% | ||
| Q3 25 | — | -859.4% | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -3951.4% | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 31.3% | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
